Cheaper synthesis route for COVID-19 drug: A collaboration with M4ALL 

Molnupiravir (MK-4482, EIDD-2801) is an experimental drug that has been demonstrated to be effective for the treatment of COVID-19 in human clinical trials. The M4ALL, a non-profit organization, is...